HCID 131735098, compound → HCID 90067408, compound

HRID 929222Notes

Reaction equation

HRID 929222 reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]2[N:22](COCC[Si](C)(C)C)[C:21]([O:31][C@H:32]3[C@H:36]4[O:37][CH2:38][CH:39]([CH2:40][C:41]([CH3:44])([OH:43])[CH3:42])[C@H:35]4[O:34][CH2:33]3)=[N:20][C:5]2=[N:6][C:7]=1[C:8]1[CH:13]=[CH:12][C:11]([C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=2)=[CH:10][CH:9]=1>C(O)(C(F)(F)F)=O.C(Cl)Cl.CCO>[Cl:1][C:2]1[CH:3]=[C:4]2[NH:22][C:21]([O:31][C@H:32]3[C@H:36]4[O:37][CH2:38][CH:39]([CH2:40][C:41]([CH3:44])([OH:43])[CH3:42])[C@H:35]4[O:34][CH2:33]3)=[N:20][C:5]2=[N:6][C:7]=1[C:8]1[CH:13]=[CH:12][C:11]([C:14]2[CH:15]=[CH:16][CH:17]=[CH:18][CH:19]=2)=[CH:10][CH:9]=1

Participants

5

Reactant 1

HCID 131735098HCID 131735098, compound

Product 1

HCID 90067408HCID 90067408, compound

Reagents, catalysts & solvents 3

HCID 702EthanolSolventHCID 6344DichloromethaneSolventHCID 6422Trifluoroacetic acidSolvent

Procedure

A mixture of 1-[(3aR,6R,6aS)-6-[6-chloro-5-(4-phenylphenyl)-1-(2-trimethylsilylethoxymethyl)-imidazo[4,5-b]pyridin-2-yl]oxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]-2-methyl-propan-2-ol (66 mg, 0.104 mmol) in TFA (0.5 mL) and DCM (1.0 mL) was stirred at room temperature. After 1.5 hours, the reaction mixture was concentrated under reduced pressure to give an oil. The oil was dissolved in EtOH (1 mL) and purified by preparative HPLC reverse phase (C-18), using a 30×150 mm Sunfire™ column and eluting with a 20%-80% acetonitrile/water+0.05% TFA gradient. The desired fractions were lyophilized to give the title compound as a solid. Major isomer LC-MS: calculated for C28H28ClN3O4 505.18 observed m/e: 506.23 (M+H)+ (Rt 1.16/2 min); 1H NMR δ (ppm) (CD3OD): 7.87 (s, 1H), 7.75 (ABq, 4H), 7.71 (d, 2H), 7.48 (dd, 2H), 7.38 (dd, 1H), 5.56 (qt, 1H), 4.96 (t, 1H), 4.54 (t, 1H), 4.10-4.00 (m, 3H), 3.51 (dd, 1H), 2.63 (m, 1H), 2.59 (m, 1H), 1.95 (dd, 1H), 1.58 (dd, 1H) and 1.25 (s, 3H).

Workup

  1. concentrationthe reaction mixture was concentrated under reduced pressure
  2. customto give an oil
  3. custompurified by preparative HPLC reverse phase (C-18)
  4. washeluting with a 20%-80% acetonitrile/water+0.05% TFA gradient

Sources & evidence

ORD record
ord-21649a0bf3fb479f997caae6bc5973cf
Source dataset
uspto-grants-2016_03
Patent number
US09290517B2

Reaction notes

Loading…